Yoshihide Takahashi

Yoshihide Takahashi

Auto-generated profile, based on publicly available information

Yoshihide Takahashi

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in JACC
Verified
Journal Article
Closed access
YTYoshihide Takahashi
Yoshihide Takahashi
MOMark D. O’nEill
Mark D. O’nEill
MHMélèze Hocini
Mélèze Hocini
RDRemi Dubois
Remi Dubois
SMSeiichiro Matsuo
Seiichiro Matsuo
MHMichel Haïssaguerre
Michel Haïssaguerre

1 March 2007 in JACC
Verified
Journal Article
Closed access
YTYoshihide Takahashi
Yoshihide Takahashi
MOMark D. O’nEill
Mark D. O’nEill
MHMéléze Hocini
Méléze Hocini
PRPatricia Reant
Patricia Reant
AJAnders Jonsson
Anders Jonsson
MHMichel Haïssaguerre
Michel Haïssaguerre

29 November 2011 in Circulation
Verified
Journal Article
Closed access
YTYoshihide Takahashi
Yoshihide Takahashi
ATAtsushi Takahashi
Atsushi Takahashi
TKTaishi Kuwahara
Taishi Kuwahara
KOKenji Okubo
Kenji Okubo
TFTadashi Fujino
Tadashi Fujino
MIMitsuaki Isobe
Mitsuaki Isobe
Background—: Kidney function is a known predictor of cardiovascular morbidity and mortality. Although patients with atrial fibrillation (AF) often have kidney dysfunction, less is known about the association between AF and kidney function. We sought to assess changes in kidney function after catheter ablation of AF. Methods and Results—: Patients who underwent catheter ablation of AF were recruited for the present prospective study. Estimated glomerular filtration rate (eGFR) was evaluated before and 1 year after the ablation. Three hundred eighty-six patients (paroxysmal AF, 135; persistent AF, 106; longstanding persistent AF, 145) were studied. Their baseline eGFR was 68±14 mL · min −1 · 1.73 m −2 . Sixty-six percent and 26% of patients had eGFR of 60 to 89 and 30 to 59 mL · min −1 · 1.73 m −2 , respectively. Overall, 278 patients (72%) were arrhythmia free over a 1-year follow-up. In patients free from arrhythmia, eGFR increased 3 months later and was maintained until 1 year, whereas in patients with recurrences, eGFR had decreased over 1 year. Changes in eGFR over 1 year in patients free from arrhythmia differed significantly compared with those with recurrences (3±8 versus −2±8 mL · min −1 · 1.73 m −2 ; P <0.0001). In all quartiles of baseline eGFR, changes in eGFR over 1 year after the ablation were greater in patients free from arrhythmia compared with those with recurrences. Conclusion—: Elimination of AF by catheter ablation was associated with improvement of kidney function over a 1-year follow-up in patients with mild to moderate kidney dysfunction.

1 June 2009 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
YTYoshihide Takahashi
Yoshihide Takahashi
ATAtsushi Takahashi
Atsushi Takahashi
SMSHINSUKE MIYAZAKI
SHINSUKE MIYAZAKI
TKTaishi Kuwahara
Taishi Kuwahara
ATAsumi Takei
Asumi Takei
MIMitsuaki Isobe
Mitsuaki Isobe

1 June 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
YTYoshihide Takahashi
Yoshihide Takahashi
JNJunichi Nitta
Junichi Nitta
AKAtsushi Kobori
Atsushi Kobori
YSYuichiro Sakamoto
Yuichiro Sakamoto
YNYasutoshi Nagata
Yasutoshi Nagata
TSTetsuo Sasano
Tetsuo Sasano
Background: Abstinence from alcohol is effective for reduction of atrial fibrillation (AF) burden. However, effects of alcohol abstinence on clinical outcomes of catheter ablation for AF remain unknown. We sought to assess association of alcohol consumption reduction with clinical outcomes of catheter ablation for AF. Methods: In this multicenter prospective observational study, consecutive patients undergoing catheter ablation for AF were enrolled. All patients were requested to limit alcohol consumption to <20 g/wk after the ablation. The primary end point was AF/atrial tachycardia (AT) recurrence-free survival without antiarrhythmic drugs beyond a 3-month blanking period. Percent reduction of alcohol consumption from baseline to 1-year postablation, if freed from AF/AT for 1-year, or to AF/AT recurrence was assessed. Univariate and multivariate Cox regression analyses were performed to assess the association of the percent reduction of alcohol consumption with AF/AT recurrence-free survival as well as to determine the cutoff value for the percent reduction of alcohol consumption that yielded the largest difference in AF/AT recurrence-free survival. Results: Of 3474 patients enrolled in this study, analysis was performed in 1720 patients who consumed alcohol regularly before ablation (64±10 years, male 88%, paroxysmal AF 55.9%, persistent AF 31.6%, longstanding persistent AF 12.5%). Median baseline alcohol consumption was 140 g/wk (interquartile range, 70–280 g). Alcohol consumption during 1-year follow-up decreased to a median of 70 g (interquartile range, 13–162 g; P <0.0001). Multivariate Cox regression analysis demonstrated that alcohol reduction of ≥1% from baseline to 1-year follow-up (median reduction, 75% [interquartile range, 45%–100%]) was associated with lower risk of AF/AT recurrence (hazard ratio, 0.630 [95% C, 0.518–0.768], P <0.001), compared with alcohol reduction of <1% (median, 0% [interquartile range, −20% to 0%]). Conclusions: This study suggests that abstinence from alcohol improves clinical outcomes of catheter ablation for AF.

11 December 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
NKNobutaka Kato
Nobutaka Kato
JNJunichi Nitta
Junichi Nitta
ASAkira Sato
Akira Sato
YIYukihiro Inamura
Yukihiro Inamura
TTTomomasa Takamiya
Tomomasa Takamiya
TSTetsuo Sasano
Tetsuo Sasano